Publications by authors named "Gilmour Morrison"

Claim this Profile
C
Cannabidiol efficacy independent of clobazam: Meta-analysis of four randomized controlled trials.
Orrin Devinsky, Elizabeth A Thiele, Stephen Wright, Daniel Checketts, Gilmour Morrison

Acta Neurol Scand· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2, Double-Blind, Placebo-Controlled Trial to Investigate Potential Drug-Drug Interactions Between Cannabidiol and Clobazam.
Kevan E VanLandingham, Julie Crockett, Lesley Taylor, Gilmour Morrison

J Clin Pharmacol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs.
Philip N Patsalos, Jerzy P Szaflarski, Barry Gidal, Kevan VanLandingham, David Critchley, Gilmour Morrison

Epilepsia· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics, Safety, and Tolerability of Cannabidiol in Subjects with Mild to Severe Renal Impairment.
Bola Tayo, Lesley Taylor, Farhad Sahebkar, Gilmour Morrison

Clin Pharmacokinet· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug-Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with Epilepsy.
Elinor Ben-Menachem, Boudewijn Gunning, Carmen María Arenas Cabrera, Kevan VanLandingham, Julie Crockett, Gilmour Morrison

CNS Drugs· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects.
Julie Crockett, David Critchley, Bola Tayo, Joris Berwaerts, Gilmour Morrison

Epilepsia· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects.
Gilmour Morrison, Julie Crockett, Graham Blakey, Kenneth Sommerville

Clin Pharmacol Drug Dev· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment.
Lesley Taylor, Julie Crockett, Bola Tayo, Gilmour Morrison

J Clin Pharmacol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.
Lesley Taylor, Barry Gidal, Graham Blakey, Bola Tayo, Gilmour Morrison

CNS Drugs· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.
Lesley Taylor, Barry Gidal, Graham Blakey, Bola Tayo, Gilmour Morrison

CNS Drugs· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.
Orrin Devinsky, Anup D Patel, Elizabeth A Thiele, Matthew H Wong, Richard Appleton, Gilmour Morrison

Neurology· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of SAR103168, a novel multi-kinase inhibitor, in patients with refractory/relapsed acute leukemia or high-risk myelodysplastic syndrome.
Gail J Roboz, H Jean Khoury, Elias Jabbour, Wilena Session, Ellen K Ritchie, J Gilmour Morrison

Leuk Lymphoma· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I dose-escalation study of SR271425, an intravenously dosed thioxanthone analog, administered weekly in patients with refractory solid tumors.
A Craig Lockhart, Emiliano Calvo, Anthony W Tolcher, Eric K Rowinsky, Gareth Shackleton, J Gilmour Morrison

Am J Clin Oncol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis